In the BioHarmony Drug Report Database

"Preview" Icon

Botulinum toxin type b

Myobloc, NeuroBloc (botulinum toxin type b) is an unknown pharmaceutical. Botulinum toxin type b was first approved as Myobloc on 2001-01-22. It is used to treat sialorrhea in the USA. It has been approved in Europe to treat torticollis.

 

Trade Name

 

NeuroBloc
 

Common Name

 

botulinum toxin type b
 

ChEMBL ID

 

CHEMBL1201569
 

Indication

 

sialorrhea, torticollis
 

Drug Class

 

Fluoroquinolone derivatives, nonantibacterial indications (e.g., antineoplastic antibiotics)

Image (chem structure or protein)

Botulinum toxin type b structure rendering